| Resistance of mice vaccinated with rabies virus internal structural proteins to lethal infection. | |
| | |
MedLine Citation:
|
PMID: 8352659 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Mice were vaccinated with recombinant vaccinia virus (rVac) expressing the glycoprotein (G), nucleoprotein (N), phosphoprotein (NS) or matrix protein (M) of rabies virus and their resistance to peripheral lethal infection with street rabies virus was examined. Mice vaccinated with rVac-G or rVac-N developed strong antibody responses to the corresponding proteins and essentially all mice survived challenge infection. Mice vaccinated with rVac-NS or rVac-M developed only a slight antibody response, however, a significant protection (59%) was observed in the rVac-NS-vaccinated mice, whereas rVac-M-vaccinated mice were not protected. No anti-G antibodies were detected in the sera of mice which has been vaccinated with rVac-N or rVac-NS and survived challenge infection. Passive transfer of anti-N monoclonal antibodies (MAbs) recognizing an epitope located on amino acids 1-224 of the protein prior to challenge resulted in significant protection, although the protection was not complete even with a high amount of antibodies. In contrast, none of the mice given MAbs recognizing an epitope of amino acids 247-415 or F(ab')2 fragments from a protective MAb IgG were protected. Administration of anti-CD 8 MAb to rVac-N-vaccinated mice showed no significant effect on protection. Our observations suggest that a considerable part of the protection achieved by the vaccination with rVac-N can be ascribed to the intact anti-N antibodies recognizing an epitope located on amino acids 1-224 of the protein. |
| | |
Authors:
|
Y Takita-Sonoda; H Fujii; K Mifune; Y Ito; M Hiraga; A Nishizono; K Mannen; N Minamoto |
Related Documents
:
|
12297389 - Characterization of protective immune responses induced by nasal influenza vaccine cont... 16558079 - Pathogenicity and immunogenicity for mice of temperature-sensitive mutants of vesicular... 20306669 - Effect of mouse strain on humoral responses to schistosoma mansoni irradiated cercariae... 19029299 - Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, p... 21110049 - Superior protection provided by a single dose of mf59-adjuvanted whole inactivated h5n1... 3104209 - Test of the virulence and live-vaccine efficacy of auxotrophic and gale derivatives of ... 23029269 - Lack of innate interferon responses during sars coronavirus infection in a vaccination ... 19501019 - Why actively promote vaccination in patients with cirrhosis? 18482379 - Occurrence of postmortem myoliquefactive kudoosis in atlantic mackerel, scomber scombru... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
Journal Detail:
|
Title: Archives of virology Volume: 132 ISSN: 0304-8608 ISO Abbreviation: Arch. Virol. Publication Date: 1993 |
Date Detail:
|
Created Date: 1993-09-15 Completed Date: 1993-09-15 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 7506870 Medline TA: Arch Virol Country: AUSTRIA |
Other Details:
|
Languages: eng Pagination: 51-65 Citation Subset: IM |
Affiliation:
|
Department of Microbiology, Oita Medical University, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antibodies, Monoclonal / administration & dosage, immunology Antibodies, Viral / administration & dosage, biosynthesis Antigens, CD8 / immunology Base Sequence Capsid / administration & dosage, immunology Cells, Cultured Cricetinae DNA, Viral Immunity, Innate Immunization, Passive Male Mice Mice, Inbred BALB C Molecular Sequence Data Rabbits Rabies / prevention & control* Rabies Vaccines / administration & dosage*, immunology Vaccines, Synthetic / administration & dosage, immunology Vaccinia virus / genetics Viral Core Proteins / administration & dosage, immunology Viral Matrix Proteins / administration & dosage, immunology Viral Nonstructural Proteins / administration & dosage, immunology Viral Structural Proteins / administration & dosage, immunology* |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Antibodies, Viral; 0/Antigens, CD8; 0/DNA, Viral; 0/Rabies Vaccines; 0/Vaccines, Synthetic; 0/Viral Core Proteins; 0/Viral Matrix Proteins; 0/Viral Nonstructural Proteins; 0/Viral Structural Proteins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Subgroup F adenovirus growth in foetal intestinal organ cultures.
Next Document: RNA hybrid mismatch polymorphisms in Australian populations of turnip yellow mosaic tymovirus.